DK1368016T3 - Parenterale indgivelsesformer indeholdende en suspension af saltet af tramadol og diclofenac - Google Patents
Parenterale indgivelsesformer indeholdende en suspension af saltet af tramadol og diclofenacInfo
- Publication number
- DK1368016T3 DK1368016T3 DK01994735T DK01994735T DK1368016T3 DK 1368016 T3 DK1368016 T3 DK 1368016T3 DK 01994735 T DK01994735 T DK 01994735T DK 01994735 T DK01994735 T DK 01994735T DK 1368016 T3 DK1368016 T3 DK 1368016T3
- Authority
- DK
- Denmark
- Prior art keywords
- diclofenac
- suspension
- salt
- tramadol
- parenteral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10059020A DE10059020A1 (de) | 2000-11-28 | 2000-11-28 | Parenteral applizierbare Darreichungsformen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1368016T3 true DK1368016T3 (da) | 2006-07-31 |
Family
ID=7664956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01994735T DK1368016T3 (da) | 2000-11-28 | 2001-11-27 | Parenterale indgivelsesformer indeholdende en suspension af saltet af tramadol og diclofenac |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6875447B2 (da) |
| EP (1) | EP1368016B1 (da) |
| JP (1) | JP4188084B2 (da) |
| CN (1) | CN100384410C (da) |
| AT (1) | ATE323477T1 (da) |
| AU (1) | AU2002224896A1 (da) |
| CY (1) | CY1105625T1 (da) |
| DE (2) | DE10059020A1 (da) |
| DK (1) | DK1368016T3 (da) |
| ES (1) | ES2262703T3 (da) |
| PT (1) | PT1368016E (da) |
| WO (1) | WO2002043723A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110201121A1 (en) * | 2005-08-24 | 2011-08-18 | Berggren Oy Ab | Method of testing a liquid sample, a test unit, and an automatized system of a plurality of test units |
| EP2128123A4 (en) * | 2007-01-29 | 2011-04-20 | Medrx Co Ltd | NON-STEROIDAL ANTI-INFLAMMATORY SALT AND ORGANIC AMINO COMPOUND AND USE THEREOF |
| JP5307835B2 (ja) * | 2008-01-14 | 2013-10-02 | バイオキット,エス.アー. | 流体中に粒子を分散させる装置およびその方法 |
| AU2013204763B2 (en) * | 2008-01-14 | 2015-06-04 | Biokit, S.A. | Device for distributing particles in a fluid and methods therefor |
| EP2281558A1 (en) * | 2009-08-06 | 2011-02-09 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical compounds of O-Desmethyl-Tramadol and COX-inhibitors |
| EP2593096A4 (en) * | 2010-07-12 | 2014-02-26 | Yung Shin Pharm Ind Co Ltd | DICLOFENAC SALT OF TRAMADOL |
| WO2012142273A1 (en) | 2011-04-12 | 2012-10-18 | Revogenex Inc. | Intravenous administration of tramadol |
| US9980900B2 (en) | 2015-12-22 | 2018-05-29 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
| US9693949B1 (en) | 2015-12-22 | 2017-07-04 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
| US10022321B2 (en) | 2016-06-30 | 2018-07-17 | Revogenex Ireland Ltd. | Intravenous administration of tramadol |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4016273A (en) * | 1975-07-16 | 1977-04-05 | American Cyanamid Company | Sustained release forms of certain oxazepines for parenteral administration |
| DE3324193A1 (de) * | 1983-07-05 | 1985-01-17 | Troponwerke Gmbh & Co Kg | Depot-antiphlogistika |
| US5283067A (en) * | 1987-01-30 | 1994-02-01 | Ciba-Geigy Corporation | Parenteral suspensions |
| ATE169498T1 (de) * | 1991-09-06 | 1998-08-15 | Mcneilab Inc | Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung |
| AU661723B2 (en) * | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| CA2143044C (en) * | 1994-02-21 | 2005-04-12 | Yasutaka Igari | Matrix for sustained-release preparation |
| PT704206E (pt) * | 1994-09-30 | 2003-01-31 | Mika Pharma G Fur Die E Und V | Composicao farmaceutica |
| AU7472798A (en) * | 1997-05-07 | 1998-11-27 | Algos Pharmaceutical Corporation | Cox-2 inhibitors in combination with nmda-blockers for treating pain |
| DE19732928C2 (de) * | 1997-07-31 | 2000-05-18 | Gruenenthal Gmbh | Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel |
| WO2000029022A1 (en) * | 1998-11-12 | 2000-05-25 | Algos Pharmaceutical Corporation | Cox-2 inhibitors in combination with centrally acting analgesics |
| CA2351224A1 (en) * | 1998-11-12 | 2000-05-25 | Algos Pharmaceutical Corporation | Cox-2 inhibitors in combination with nmda-blockers for treating pain |
| JP4722295B2 (ja) * | 1999-05-27 | 2011-07-13 | エイカスフィアー・インコーポレーテッド | 多孔性薬剤マトリクスおよびその製造方法 |
-
2000
- 2000-11-28 DE DE10059020A patent/DE10059020A1/de not_active Withdrawn
-
2001
- 2001-11-27 AT AT01994735T patent/ATE323477T1/de active
- 2001-11-27 WO PCT/EP2001/013789 patent/WO2002043723A1/de not_active Ceased
- 2001-11-27 DE DE50109572T patent/DE50109572D1/de not_active Expired - Lifetime
- 2001-11-27 DK DK01994735T patent/DK1368016T3/da active
- 2001-11-27 PT PT01994735T patent/PT1368016E/pt unknown
- 2001-11-27 JP JP2002545694A patent/JP4188084B2/ja not_active Expired - Fee Related
- 2001-11-27 CN CNB018196829A patent/CN100384410C/zh not_active Expired - Fee Related
- 2001-11-27 ES ES01994735T patent/ES2262703T3/es not_active Expired - Lifetime
- 2001-11-27 EP EP01994735A patent/EP1368016B1/de not_active Expired - Lifetime
- 2001-11-27 AU AU2002224896A patent/AU2002224896A1/en not_active Abandoned
-
2003
- 2003-05-21 US US10/442,701 patent/US6875447B2/en not_active Expired - Fee Related
-
2006
- 2006-06-26 CY CY20061100859T patent/CY1105625T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE10059020A1 (de) | 2002-05-29 |
| JP4188084B2 (ja) | 2008-11-26 |
| US6875447B2 (en) | 2005-04-05 |
| ES2262703T3 (es) | 2006-12-01 |
| US20030203037A1 (en) | 2003-10-30 |
| JP2004514692A (ja) | 2004-05-20 |
| HK1060971A1 (en) | 2004-09-03 |
| ATE323477T1 (de) | 2006-05-15 |
| WO2002043723A1 (de) | 2002-06-06 |
| AU2002224896A1 (en) | 2002-06-11 |
| EP1368016B1 (de) | 2006-04-19 |
| CN100384410C (zh) | 2008-04-30 |
| CY1105625T1 (el) | 2010-12-22 |
| PT1368016E (pt) | 2006-08-31 |
| DE50109572D1 (de) | 2006-05-24 |
| CN1477955A (zh) | 2004-02-25 |
| EP1368016A1 (de) | 2003-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS6957A (is) | Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim | |
| DK1487493T3 (da) | Konjugater af cytotoksiske midler og biologisk aktive peptider | |
| NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| NO20030627D0 (no) | Hydrogel-drevet medikament doseringsform | |
| ATE514418T1 (de) | Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan | |
| PT1207867E (pt) | Formas de administracao farmaceuticas orais retardadas contendo tramadol | |
| DK1178958T3 (da) | N-cyanomethylamider som proteaseinhibitorer | |
| DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
| DE60333294D1 (de) | Kontrollierte verabreichung von arzneien | |
| IS2457B (is) | Samsetningar af lyfjum (t.d. klórprómasíni og pentamídíni) fyrir meðhöndlun á æxlistruflunum | |
| DK1296671T3 (da) | Gabapentinanaloger til sövnforstyrrelser | |
| DK1372624T3 (da) | Lægemiddel på basis af tramadol | |
| DK1557415T3 (da) | Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens | |
| MA27115A1 (fr) | Sel de perindopril et les compositions pharmaceutiques qui les contiennent | |
| DK1280799T3 (da) | Orthosubstituerede anthranilsyreamider og anvendelse heraf som lægemidler | |
| DE50301661D1 (de) | Darreichungsform von Ibuprofen-Natrium | |
| DK1368016T3 (da) | Parenterale indgivelsesformer indeholdende en suspension af saltet af tramadol og diclofenac | |
| ATE432068T1 (de) | Cetirizin und pseudoephedrin enthaltende tablette | |
| DK1781277T3 (da) | Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol | |
| ID27771A (id) | Turunan triazol-piridazin tersubstitusi, komposisi farmasi yang dibuat dari bahan itu | |
| DE60225686D1 (de) | Paracetamol enthaltende tablette | |
| HRP20031057B1 (hr) | Tableta koja sadrži cetirizin i pseudoefedrin | |
| BRPI0417265A (pt) | composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna | |
| DK1161239T3 (da) | 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose | |
| EP1399467A4 (en) | PRODRUGS ACTIVATED BY PEPTIDDEFORMYLASE |